Starling Oncology (STLNW) Prepaid Assets (2020 - 2026)

Starling Oncology (STLNW) has reported Prepaid Assets for 7 consecutive years, with $1.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Prepaid Assets fell 57.68% year-over-year to $1.2 million; the trailing twelve-month figure through Jun 2026 stood at $1.2 million (down 57.68% YoY), and the FY2025 full-year result was $3.0 million, down 25.86% from the prior year.
• Prepaid Assets eased to $1.2 million in Q2 2026 per STLNW's latest filing, from $2.8 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $10.7 million in Q1 2022 and bottomed at $1.2 million in Q2 2026.
• Historically, Prepaid Assets has averaged $5.1 million across 5 years, with a median of $4.2 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Prepaid Assets surged 9207.56% in 2022, then sank 57.68% in 2026.
• Over 5 years, Prepaid Assets stood at $6.9 million in 2022, then tumbled by 41.47% to $4.0 million in 2023, then declined by 0.49% to $4.0 million in 2024, then decreased by 25.86% to $3.0 million in 2025, then plunged by 60.63% to $1.2 million in 2026.
• According to Business Quant data, Prepaid Assets over the past three periods registered $1.2 million, $2.8 million, and $3.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.